Overseas Exhibition Preview | Nanodigmbio Invites You to the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) in Boston

✨ NGS Technology Breaks New Ground! Newborn Genetic Screening Adds More "Lines of Defense" for HealthWith the maturity of Next-Generation Sequencing (NGS) technology, newborn genetic screening has finally arrived—it does not test "biochemical indicators" but directly analyzes a baby’s DNA, acting like a "genetic detective" to identify hidden genetic disease risks. Compar...

NanoHema Panel v2.0 integrates a synergistic DNA and RNA dual workflow, enabling multidimensional analysis of genetic alterations. DNA detection provides broad coverage for mutation screening, while RNA detection precisely confirms fusion expression and functionality, collectively ensuring comprehensive and accurate results. This multi-omics integration strategy not only...

Nanodigmbio’s HLA Typing Comprehensive Solution, based on probe-based liquid-phase hybridization capture, is fully compatible with MGI's DNBSEQ sequencing platforms (DNBSEQ-E25, DNBSEQ-G99, and MGISEQ-2000). Owning to Nanodigmbio’s extremely streamlined hybridization process and the high accuracy, sensitivity, ultra-low duplication, and minimal index hopping rate of the ...